Shareholders’ Equity (Details) |
1 Months Ended | 12 Months Ended | |||||
---|---|---|---|---|---|---|---|
Jun. 30, 2023
USD ($)
$ / shares
shares
|
Dec. 31, 2023
USD ($)
|
Dec. 31, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2023
₪ / shares
shares
|
Dec. 31, 2022
₪ / shares
shares
|
Dec. 31, 2016
shares
|
|
Shareholders’ Equity [Line Items] | |||||||
Ordinary shares, authorized (in Shares) | 130,000,000 | 130,000,000 | |||||
Ordinary shares, par value (in New Shekels per share) | ₪ / shares | ₪ 0.000216 | ₪ 0.000216 | |||||
Stock split | the Company effected a 1:46.25783 stock split | ||||||
Ordinary shares issue value | $ | $ 23,000 | ||||||
Ordinary shares issue (in Shares) | 11,794,873 | ||||||
Share Price (in Dollars per share) | $ / shares | $ 1.95 | ||||||
Net of issuance costs | $ | $ 22,496 | $ 22,496,000 | |||||
Plan expiration period | 7 years | ||||||
Expected dividend yield | 0.00% | ||||||
Stock-based compensation | $ | $ 629,000 | $ 354,000 | $ 115,000 | ||||
2016 Share Incentive Plan [Member] | Ordinary Shares [Member] | |||||||
Shareholders’ Equity [Line Items] | |||||||
Ordinary shares were reserved for issuance (in Shares) | 3,384,454 | ||||||
2021 Plan [Member] | |||||||
Shareholders’ Equity [Line Items] | |||||||
Ordinary shares were reserved for issuance (in Shares) | 4,079,427 | ||||||
Options vested period | 4 years | ||||||
Share option , description | (i) 5% of the total number of ordinary shares outstanding on December 31 of the immediately preceding calendar year, and (ii) an amount determined by the Board, if so determined prior to the January 1 of the calendar year in which the increase will occur | ||||||
Vesting period, description | The vesting period of the awards is generally four years. Generally, under the terms of the Plans, unless determined otherwise, 25% of an award granted becomes exercisable on the first anniversary of the date of grant and 6.25% becomes exercisable once every quarter during the subsequent three years. | ||||||
2016 Plan [Member] | |||||||
Shareholders’ Equity [Line Items] | |||||||
Options vested period | 4 years |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Stated value of common units of ownership issued by a limited liability company (LLC). No definition available.
|
X | ||||||||||
- Definition Number of common units issued of limited liability company (LLC). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Description of terms of award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the expected term of a nonvested share or option award issued to other than an employee. Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef
|
X | ||||||||||
- Definition Price of a single share of a number of saleable stocks of a company. No definition available.
|
X | ||||||||||
- Definition Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|